BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11915009)

  • 1. The effects of statins on mortality rates among bacteremic patients.
    Stefanec T
    Clin Infect Dis; 2002 Apr; 34(8):1158. PubMed ID: 11915009
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of statins on mortality in patients with bacteremia.
    Liappis AP; Kan VL; Rochester CG; Simon GL
    Clin Infect Dis; 2001 Oct; 33(8):1352-7. PubMed ID: 11565076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and mortality in the bacteremic critically ill patient.
    Corona A; Raimondi F; Singer M
    Crit Care Med; 2006 Apr; 34(4):1270-2. PubMed ID: 16550088
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hyperlipidemia in cardiac transplant recipients.
    Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
    Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and mortality within 180 days after bacteremia: a population-based cohort study.
    Thomsen RW; Hundborg HH; Johnsen SP; Pedersen L; Sørensen HT; Schønheyder HC; Lervang HH
    Crit Care Med; 2006 Apr; 34(4):1080-6. PubMed ID: 16484926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin: two decades in a circle.
    Kolovou GD; Katerina A; Ioannis V; Cokkinos DV
    Cardiovasc Ther; 2008; 26(2):166-78. PubMed ID: 18485137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role for statins in the treatment of multiple sclerosis.
    Darlington CL
    Curr Opin Investig Drugs; 2005 Jul; 6(7):667-71. PubMed ID: 16044661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins prevent strokes in high-risk patients.
    J Fam Pract; 2004 Jul; 53(7):522. PubMed ID: 15251087
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M; Böhm F; Rydén L; Pernow J
    Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis.
    Chen MS; Xu FP; Wang YZ; Zhang GP; Yi Q; Zhang HQ; Luo JD
    J Mol Cell Cardiol; 2004 Oct; 37(4):889-96. PubMed ID: 15380679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.
    Sukhija R; Aronow WS; Sandhu R; Kakar P; Babu S
    Am J Cardiol; 2006 Jan; 97(2):279-80. PubMed ID: 16442379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SBU should investigate what is an evidence-based and cost-effective use of statins].
    Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of statins in vascular protection.
    Mason JC
    Clin Adv Hematol Oncol; 2007 May; 5(5):352-4. PubMed ID: 17673889
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [About: pleiotropic effects of statins in atherosclerosis].
    Ambrosi P
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1263; author reply 1263-5. PubMed ID: 16435610
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.